Pharmacology and toxicology of amphetamine and related designer drugs:
Gespeichert in:
Format: | Buch |
---|---|
Sprache: | English |
Veröffentlicht: |
Rockville, Md.
1989
|
Schriftenreihe: | National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series
94 |
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | X, 365 S. |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV004562896 | ||
003 | DE-604 | ||
005 | 19911016 | ||
007 | t | ||
008 | 911014s1989 |||| 00||| engod | ||
035 | |a (OCoLC)21158382 | ||
035 | |a (DE-599)BVBBV004562896 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
049 | |a DE-12 | ||
050 | 0 | |a RC566.A1 | |
050 | 0 | |a RM666.A493 | |
082 | 0 | |a 615/.785 |2 20 | |
245 | 1 | 0 | |a Pharmacology and toxicology of amphetamine and related designer drugs |c ed.: Khursheed Asghar ... |
264 | 1 | |a Rockville, Md. |c 1989 | |
300 | |a X, 365 S. | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series |v 94 | |
650 | 7 | |a Amfetamine |2 gtt | |
650 | 4 | |a Amphetamines |x Physiological effect |v Congresses | |
650 | 4 | |a Amphetamines |x Research |z United States |v Congresses | |
650 | 4 | |a Amphetamines |x Toxicology |v Congresses | |
650 | 4 | |a Amphetamines |x pharmacology |v Congresses | |
650 | 4 | |a Amphetamines |x toxicity |v Congresses | |
650 | 4 | |a Designer Drugs |x pharmacology |v Congresses | |
650 | 4 | |a Designer Drugs |x toxicity |v Congresses | |
650 | 4 | |a Designer drugs |x Physiological effect |v Congresses | |
650 | 4 | |a Designer drugs |x Toxicology |v Congresses | |
650 | 0 | 7 | |a Toxizität |0 (DE-588)4078372-8 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Amphetamine |0 (DE-588)4122043-2 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
651 | 4 | |a USA | |
655 | 7 | |0 (DE-588)1071861417 |a Konferenzschrift |y 1988 |z Bethesda Md. |2 gnd-content | |
689 | 0 | 0 | |a Amphetamine |0 (DE-588)4122043-2 |D s |
689 | 0 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Amphetamine |0 (DE-588)4122043-2 |D s |
689 | 1 | 1 | |a Toxizität |0 (DE-588)4078372-8 |D s |
689 | 1 | |5 DE-604 | |
700 | 1 | |a Asghar, Khursheed |e Sonstige |4 oth | |
830 | 0 | |a National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series |v 94 |w (DE-604)BV001902214 |9 94 | |
856 | 4 | 2 | |m GBV Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=002806803&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-002806803 |
Datensatz im Suchindex
_version_ | 1804118692596809728 |
---|---|
adam_text | PHARMACOLOGY AND TOXICOLOGY OF AMPHETAMINE AND RELATED DESIGNER DRUGS
EDITORS: KHURSHEED ASGHAR, PH.D. DIVISION OF PRECLINICAL RESEARCH
NATIONAL INSTITUTE ON DRUG ABUSE ERROL DE SOUZA, PH.D. ADDICTION
RESEARCH CENTER NATIONAL INSTITUTE ON DRUG ABUSE NIDA RESEARCH MONOGRAPH
94 1989 U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES PUBLIC HEALTH
SERVICE ALCOHOL, DRUG ABUSE, AND MENTAL HEALTH ADMINISTRATION NATIONAL
INSTITUTE ON DRUG ABUSE 5600 FISHERS LANE ROCKVILLE, MD 20857 FOR SALE
BY THE SUPERINTENDENT OF DOCUMENTS, U.S. GOVERNMENT PRINTING OFFICE
WASHINGTON, DC 20402 CONTENTS PAGE PREFACE IX STRUCTURE-ACTIVITY
RELATIONSHIPS OF MDMA-LIKE SUBSTANCES 1 DAVID E. NICHOLS AND ROBERT
OBERLENDER SELF-INJECTION IN BABOONS OF AMPHETAMINES AND RELATED
DESIGNER DRUGS 30 CA. SANNERUD, J.V. BRADY, AND RJT. GRIFFITHS STIMULUS
PROPERTIES OF HALLUCINOGENIC PHENALKYLAMINES AND RELATED DESIGNER DRUGS:
FORMULATION OF STRUCTURE-ACTIVITY RELATIONSHIPS 43 RICHARD A. GLENNON
AMPHETAMINES: AGGRESSIVE AND SOCIAL BEHAVIOR 68 KLAUS A. MICZEK AND
JENNIFER W. TIDEY NEUROCHEMICAL MECHANISMS INVOLVED IN BEHAVIORAL
EFFECTS OF AMPHETAMINES AND RELATED DESIGNER DRUGS 101 LISA H. GOLD,
MARK A. GEYER, AND GEORGE F. KOOB NEURONAL ACTIONS OF AMPHETAMINE IN THE
RAT BRAIN 127 PHILIP M. GROVES, LAWRENCE J. RYAN, MARCO DIANA, STEPHEN
J. YOUNG, AND LISA J. FISHER PAGE METHAMPHETAMINE AND RELATED DRUGS:
TOXICITY AND RESULTING BEHAVIORAL CHANGES IN RESPONSE TO PHARMACOLOGICAL
PROBES 146 LEWIS S. SEIDEN AND MARK S. KLEVEN ROLE OF DOPAMINE IN THE
NEUROTOXICITY INDUCED BY AMPHETAMINES AND RELATED DESIGNER DRUGS 161
JAMES W. GIBB, DONNA M. STONE, MICHEL JOHNSON, AND GLEN R. HANSON ACUTE
AND LONG-TERM NEUROCHEMICAL EFFECTS OF METHYLENEDIOXYMETHAMPHETAMINE IN
THE RAT 179 CHRISTOPHER J. SCHMIDT EFFECTS OF MDMA AND MDA ON BRAIN
SEROTONIN NEURONS: EVIDENCE FROM NEUROCHEMICAL AND AUTORADIOGRAPHIC
STUDIES 196 ERROL B. DE SOUZA AND GEORGE BATTAGLIA CHARACTERIZATION OF
BRAIN INTERACTIONS WITH METHYLENEDIOXYAMPHETAMINE AND
METHYLENEDIOXYMETHAMPHETAMINE 223 ROBERT ZACZEK, STEPHEN HURT, STEVEN
CULP, AND ERROL B. DE SOUZA PHARMACOLOGIC PROFILE OF AMPHETAMINE
DERIVATIVES AT VARIOUS BRAIN RECOGNITION SITES: SELECTIVE EFFECTS ON
SEROTONERGIC SYSTEMS 240 GEORGE BATTAGLIA AND ERROL B. DE SOUZA EFFECTS
OF AMPHETAMINE ANALOGS ON CENTRAL NERVOUS SYSTEM NEUROPEPTIDE SYSTEMS
259 GLEN R. HANSON, PATRICIA SOMALIA, ANITA LETTER, KALPANA M. MERCHANT,
MICHEL JOHNSON, LLOYD BUSH, AND JAMES W. GIBB EFFECTS OF NEUROTOXIC
AMPHETAMINES ON SEROTONERGIC NEURONS: IMMUNOCYTOCHEMICAL STUDIES 270
MARK E. MOLLIVER, LAURA A. MAMOUNAS, AND MARY ANN WILSON STUDIES OF
MDMA-INDUCED NEUROTOXICITY IN NONHUMAN PRIMATES: A BASIS FOR EVALUATING
LONG-TERM EFFECTS IN HUMANS 306 GEORGE A. RICAURTE VI PAGE DOSE- AND
TIME-DEPENDENT EFFECTS OF STIMULANTS 323 EVERETT H. ELLINWOOD, JR., AND
TONG H. LEE RECOMMENDATIONS FOR FUTURE RESEARCH ON AMPHETAMINES AND
RELATED DESIGNER DRUGS 341 RAY W. FULLER LIST OF NIDA RESEARCH
MONOGRAPHS 358 VU
|
any_adam_object | 1 |
building | Verbundindex |
bvnumber | BV004562896 |
callnumber-first | R - Medicine |
callnumber-label | RC566 |
callnumber-raw | RC566.A1 RM666.A493 |
callnumber-search | RC566.A1 RM666.A493 |
callnumber-sort | RC 3566 A1 |
callnumber-subject | RC - Internal Medicine |
ctrlnum | (OCoLC)21158382 (DE-599)BVBBV004562896 |
dewey-full | 615/.785 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615/.785 |
dewey-search | 615/.785 |
dewey-sort | 3615 3785 |
dewey-tens | 610 - Medicine and health |
discipline | Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02328nam a2200565 cb4500</leader><controlfield tag="001">BV004562896</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">19911016 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">911014s1989 |||| 00||| engod</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)21158382</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV004562896</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC566.A1</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RM666.A493</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615/.785</subfield><subfield code="2">20</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Pharmacology and toxicology of amphetamine and related designer drugs</subfield><subfield code="c">ed.: Khursheed Asghar ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Rockville, Md.</subfield><subfield code="c">1989</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">X, 365 S.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series</subfield><subfield code="v">94</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Amfetamine</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Amphetamines</subfield><subfield code="x">Physiological effect</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Amphetamines</subfield><subfield code="x">Research</subfield><subfield code="z">United States</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Amphetamines</subfield><subfield code="x">Toxicology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Amphetamines</subfield><subfield code="x">pharmacology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Amphetamines</subfield><subfield code="x">toxicity</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Designer Drugs</subfield><subfield code="x">pharmacology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Designer Drugs</subfield><subfield code="x">toxicity</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Designer drugs</subfield><subfield code="x">Physiological effect</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Designer drugs</subfield><subfield code="x">Toxicology</subfield><subfield code="v">Congresses</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Toxizität</subfield><subfield code="0">(DE-588)4078372-8</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Amphetamine</subfield><subfield code="0">(DE-588)4122043-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="4"><subfield code="a">USA</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)1071861417</subfield><subfield code="a">Konferenzschrift</subfield><subfield code="y">1988</subfield><subfield code="z">Bethesda Md.</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Amphetamine</subfield><subfield code="0">(DE-588)4122043-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Amphetamine</subfield><subfield code="0">(DE-588)4122043-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Toxizität</subfield><subfield code="0">(DE-588)4078372-8</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Asghar, Khursheed</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series</subfield><subfield code="v">94</subfield><subfield code="w">(DE-604)BV001902214</subfield><subfield code="9">94</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">GBV Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=002806803&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-002806803</subfield></datafield></record></collection> |
genre | (DE-588)1071861417 Konferenzschrift 1988 Bethesda Md. gnd-content |
genre_facet | Konferenzschrift 1988 Bethesda Md. |
geographic | USA |
geographic_facet | USA |
id | DE-604.BV004562896 |
illustrated | Not Illustrated |
indexdate | 2024-07-09T16:14:20Z |
institution | BVB |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-002806803 |
oclc_num | 21158382 |
open_access_boolean | |
owner | DE-12 |
owner_facet | DE-12 |
physical | X, 365 S. |
publishDate | 1989 |
publishDateSearch | 1989 |
publishDateSort | 1989 |
record_format | marc |
series | National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series |
series2 | National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series |
spelling | Pharmacology and toxicology of amphetamine and related designer drugs ed.: Khursheed Asghar ... Rockville, Md. 1989 X, 365 S. txt rdacontent n rdamedia nc rdacarrier National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series 94 Amfetamine gtt Amphetamines Physiological effect Congresses Amphetamines Research United States Congresses Amphetamines Toxicology Congresses Amphetamines pharmacology Congresses Amphetamines toxicity Congresses Designer Drugs pharmacology Congresses Designer Drugs toxicity Congresses Designer drugs Physiological effect Congresses Designer drugs Toxicology Congresses Toxizität (DE-588)4078372-8 gnd rswk-swf Amphetamine (DE-588)4122043-2 gnd rswk-swf Pharmakologie (DE-588)4045687-0 gnd rswk-swf USA (DE-588)1071861417 Konferenzschrift 1988 Bethesda Md. gnd-content Amphetamine (DE-588)4122043-2 s Pharmakologie (DE-588)4045687-0 s DE-604 Toxizität (DE-588)4078372-8 s Asghar, Khursheed Sonstige oth National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series 94 (DE-604)BV001902214 94 GBV Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=002806803&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Pharmacology and toxicology of amphetamine and related designer drugs National Institute on Drug Abuse <Rockville, Md.>: NIDA research monograph series Amfetamine gtt Amphetamines Physiological effect Congresses Amphetamines Research United States Congresses Amphetamines Toxicology Congresses Amphetamines pharmacology Congresses Amphetamines toxicity Congresses Designer Drugs pharmacology Congresses Designer Drugs toxicity Congresses Designer drugs Physiological effect Congresses Designer drugs Toxicology Congresses Toxizität (DE-588)4078372-8 gnd Amphetamine (DE-588)4122043-2 gnd Pharmakologie (DE-588)4045687-0 gnd |
subject_GND | (DE-588)4078372-8 (DE-588)4122043-2 (DE-588)4045687-0 (DE-588)1071861417 |
title | Pharmacology and toxicology of amphetamine and related designer drugs |
title_auth | Pharmacology and toxicology of amphetamine and related designer drugs |
title_exact_search | Pharmacology and toxicology of amphetamine and related designer drugs |
title_full | Pharmacology and toxicology of amphetamine and related designer drugs ed.: Khursheed Asghar ... |
title_fullStr | Pharmacology and toxicology of amphetamine and related designer drugs ed.: Khursheed Asghar ... |
title_full_unstemmed | Pharmacology and toxicology of amphetamine and related designer drugs ed.: Khursheed Asghar ... |
title_short | Pharmacology and toxicology of amphetamine and related designer drugs |
title_sort | pharmacology and toxicology of amphetamine and related designer drugs |
topic | Amfetamine gtt Amphetamines Physiological effect Congresses Amphetamines Research United States Congresses Amphetamines Toxicology Congresses Amphetamines pharmacology Congresses Amphetamines toxicity Congresses Designer Drugs pharmacology Congresses Designer Drugs toxicity Congresses Designer drugs Physiological effect Congresses Designer drugs Toxicology Congresses Toxizität (DE-588)4078372-8 gnd Amphetamine (DE-588)4122043-2 gnd Pharmakologie (DE-588)4045687-0 gnd |
topic_facet | Amfetamine Amphetamines Physiological effect Congresses Amphetamines Research United States Congresses Amphetamines Toxicology Congresses Amphetamines pharmacology Congresses Amphetamines toxicity Congresses Designer Drugs pharmacology Congresses Designer Drugs toxicity Congresses Designer drugs Physiological effect Congresses Designer drugs Toxicology Congresses Toxizität Amphetamine Pharmakologie USA Konferenzschrift 1988 Bethesda Md. |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=002806803&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
volume_link | (DE-604)BV001902214 |
work_keys_str_mv | AT asgharkhursheed pharmacologyandtoxicologyofamphetamineandrelateddesignerdrugs |